Tivantinib (ARQ 197) vs Placebo in patients with Hepatocellular Carcinoma (HCC) who failed one systemic therapy: results of a randomized controlled phase 2 trial
ONKOLOGIE(2012)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined